Idorsia’s Insomnia Drug Daridorexant Among 14 Hopefuls For EU Verdict

Immunocore’s Tebentafusp Could Also Get A Marketing Recommendation

 
• By Vibha Sharma

The European Medicines Agency will likely decide this week whether to recommend for pan-EU approval new treatments for insomnia, uveal melanoma, migraine and advanced prostate cancer.

Thumbs
Yes Or No? Its Crunch Time For Companies As EMA Meets To Adopt Opinions On Several Marketing Authorization Applications • Source: Shutterstock: Little Pig Studio

More from Europe

More from Geography